Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Fresenius Kabi USA, LLC recalls Xylocaine (lidocaine HCl Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of Particulate Matter: Hair was found in products
Products
  • Xylocaine (lidocaine HCl Injection
Where it was sold

Nationwide within in the USA

Nationwide

Units affected
93,250 vials
About this recall
Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01